The INVOS™ system is the only cerebral/somatic oximetry system with FDA cleared improved outcome claims.([FOOTNOTE=Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.],[ANCHOR=],[LINK=]),([FOOTNOTE=Casati A, Fanelli G, Pietropaoli P, et al. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005;101(3):740-747.],[ANCHOR=],[LINK=]),([FOOTNOTE=FDA 510(k) K082327 REF: 886-11-PM-0256BRC],[ANCHOR=],[LINK=])
The INVOS™ system provides real-time monitoring of changes in regional oxygen saturation (rSO2) of blood in the brain or other body tissues beneath the sensor for effective oxygen monitoring in adults, children, infants and neonates.
This unique system allows clinicians to measure site-specific oxygen levels rather than requiring them to infer the data from systemic, whole body measures such as blood pressure and pulse oximetry. Available in two or four data channels, clinicians can conveniently monitor multiple brain and body areas.
See how the INVOS™ analytics resource facilitates evaluation of regional oxygenation case data.
Make an informed choice for NIRS by examining the response time to patient hypoxia.
Review recent clinical evidence (10,778 patients) supporting the use of INVOSTM in Cardiac Surgery.
Learn more about how INVOS™ technology provides clinicians with immediate, actionable information to optimise patient care.